Sone Capital Management’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
UCFA
VCM
VPM
MC
Sone Capital Management's RGEN Position: Q1 2026 in Review
Sone Capital Management increased its Repligen (RGEN) stake by 40% in Q1 2026, buying an estimated $1.57M and bringing the position to 39,340 shares worth $4.64M. The position accounts for 0.39% of the portfolio, ranked #70.
Sone Capital Management first reported a position in RGEN in Q1 2025 and has held it in 5 quarters since. The position peaked at $18.5M in Q3 2025. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.
- Sone Capital Management held 39,340 shares of Repligen worth $4.64M as of Q1 2026.
- Sone Capital Management bought 11,222 Repligen shares in Q1 2026, an estimated $1.57M.
- Repligen made up 0.39% of Sone Capital Management's portfolio in Q1 2026, its #70 holding.
- Sone Capital Management first reported a position in Repligen in Q1 2025 and has held it in 5 quarters since.
- Sone Capital Management's Repligen position peaked at $18.5M in Q3 2025.
- 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.
Based on Sone Capital Management's 13F filing for Q1 2026, filed 15 May 2026.